CRMP4-mediated fornix development involves semaphorin-3E signaling pathway

  1. Benoît Boulan
  2. Charlotte Ravanello
  3. Amandine Peyrel
  4. Christophe Bosc
  5. Christian Delphin
  6. Florence Appaix
  7. Eric Denarier
  8. Alexandra Kraut
  9. Muriel Jaquier-Sarlin
  10. Alyson Fournier
  11. Annie Andrieux
  12. Sylvie Gory-Fauré  Is a corresponding author
  13. Jean-Christophe Deloulme  Is a corresponding author
  1. Institut de Recherches Cliniques de Montréal, Canada
  2. University Grenoble Alpes, France
  3. Université Grenoble Alpes, France
  4. McGill University, Canada

Abstract

Neurodevelopmental axonal pathfinding plays a central role in correct brain wiring and subsequent cognitive abilities. Within the growth cone, various intracellular effectors transduce axonal guidance signals by remodeling the cytoskeleton. Semaphorin-3E (Sema3E) is a guidance cue implicated in development of the fornix, a neuronal tract connecting the hippocampus to the hypothalamus. Microtubule-Associated Protein 6 (MAP6) has been shown to be involved in the Sema3E growth-promoting signaling pathway. In this study, we identified the Collapsin Response Mediator Protein 4 (CRMP4) as a MAP6 partner and a crucial effector in Sema3E growth-promoting activity. CRMP4-KO mice displayed abnormal fornix development reminiscent of that observed in Sema3E-KO mice. CRMP4 was shown to interact with the Sema3E tripartite receptor complex within Detergent-Resistant Membrane (DRM) domains, and DRM domain integrity was required to transduce Sema3E signaling through the Akt/GSK3 pathway. Finally, we showed that the cytoskeleton-binding domain of CRMP4 is required for Sema3E's growth-promoting activity, suggesting that CRMP4 plays a role at the interface between Sema3E receptors, located in DRM domains, and the cytoskeleton network. As the fornix is affected in many psychiatric diseases, such as schizophrenia, our results provide new insights to better understand the neurodevelopmental components of these diseases.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 2, Figure 4, Figure 5, Figure 6 , Figure 7, Figure 8, Figure 9, Figure 10 and supplementary File 1

Article and author information

Author details

  1. Benoît Boulan

    Cellular Neurobiology Research Unit, Institut de Recherches Cliniques de Montréal, Montréal, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6793-5378
  2. Charlotte Ravanello

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Amandine Peyrel

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Christophe Bosc

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Christian Delphin

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Florence Appaix

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Eric Denarier

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4169-397X
  8. Alexandra Kraut

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Muriel Jaquier-Sarlin

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8501-7511
  10. Alyson Fournier

    Department of Neurology and Neurosurgery, Montréal Neurological Institute, McGill University, Montréal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Annie Andrieux

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4022-6405
  12. Sylvie Gory-Fauré

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    For correspondence
    sylvie.gory-faure@univ-grenoble-alpes.fr
    Competing interests
    The authors declare that no competing interests exist.
  13. Jean-Christophe Deloulme

    Inserm, U1216, CEA, Grenoble Institut Neurosciences, University Grenoble Alpes, Grenoble, France
    For correspondence
    Jean-Christophe.deloulme@univ-grenoble-alpes.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2234-5865

Funding

Agence Nationale de la Recherche (2010- Blanc-120201 CBioS)

  • Christophe Bosc

Agence Nationale de la Recherche (2017-CE11-0026 MAMAs)

  • Annie Andrieux

The funder had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The study protocol was approved by the local animal welfare committee (Comité Local GIN, C2EA-04 - APAFIS number 8303-2016060110523424) and complied with EU guidelines (directive 2010/63/EU). Every precaution was taken to minimize the number of animals used and stress to animals during experiments.

Copyright

© 2021, Boulan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 857
    views
  • 137
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Benoît Boulan
  2. Charlotte Ravanello
  3. Amandine Peyrel
  4. Christophe Bosc
  5. Christian Delphin
  6. Florence Appaix
  7. Eric Denarier
  8. Alexandra Kraut
  9. Muriel Jaquier-Sarlin
  10. Alyson Fournier
  11. Annie Andrieux
  12. Sylvie Gory-Fauré
  13. Jean-Christophe Deloulme
(2021)
CRMP4-mediated fornix development involves semaphorin-3E signaling pathway
eLife 10:e70361.
https://doi.org/10.7554/eLife.70361

Share this article

https://doi.org/10.7554/eLife.70361

Further reading

    1. Developmental Biology
    Huishan Wang, Xingyan Liu ... Pengcheng Ma
    Research Article

    The spatial and temporal linear expression of Hox genes establishes a regional Hox code, which is crucial for the antero-posterior (A-P) patterning, segmentation, and neuronal circuit development of the hindbrain. RNF220, an E3 ubiquitin ligase, is widely involved in neural development via targeting of multiple substrates. Here, we found that the expression of Hox genes in the pons was markedly up-regulated at the late developmental stage (post-embryonic day E15.5) in Rnf220-/- and Rnf220+/- mouse embryos. Single-nucleus RNA sequencing (RNA-seq) analysis revealed different Hox de-repression profiles in different groups of neurons, including the pontine nuclei (PN). The Hox pattern was disrupted and the neural circuits were affected in the PN of Rnf220+/- mice. We showed that this phenomenon was mediated by WDR5, a key component of the TrxG complex, which can be polyubiquitinated and degraded by RNF220. Intrauterine injection of WDR5 inhibitor (WDR5-IN-4) and genetic ablation of Wdr5 in Rnf220+/- mice largely recovered the de-repressed Hox expression pattern in the hindbrain. In P19 embryonal carcinoma cells, the retinoic acid-induced Hox expression was further stimulated by Rnf220 knockdown, which can also be rescued by Wdr5 knockdown. In short, our data suggest a new role of RNF220/WDR5 in Hox pattern maintenance and pons development in mice.

    1. Developmental Biology
    2. Ecology
    Stav Talal, Jon F Harrison ... Arianne J Cease
    Research Article

    Organisms require dietary macronutrients in specific ratios to maximize performance, and variation in macronutrient requirements plays a central role in niche determination. Although it is well recognized that development and body size can have strong and predictable effects on many aspects of organismal function, we lack a predictive understanding of ontogenetic or scaling effects on macronutrient intake. We determined protein and carbohydrate intake throughout development on lab populations of locusts and compared to late instars of field populations. Self-selected protein:carbohydrate targets declined dramatically through ontogeny, due primarily to declines in mass-specific protein consumption rates which were highly correlated with declines in specific growth rates. Lab results for protein consumption rates partly matched results from field-collected locusts. However, field locusts consumed nearly double the carbohydrate, likely due to higher activity and metabolic rates. Combining our results with the available data for animals, both across species and during ontogeny, protein consumption scaled predictably and hypometrically, demonstrating a new scaling rule key for understanding nutritional ecology.